Putting the 'Q' in depression QALYs: A comparison of utility measurement using EQ-5D and SF-6D health related quality of life measures

Social Psychiatry and Psychiatric Epidemiology

Volumn 44, Issue 7, 2009, Pages 569-578

  Mann, Rachel ^a   Gilbody, Simon ^a   Richards, David ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

EQ 5D; Health related utility; Outcomes measurement; Quality of life; SF 6D

Indexed keywords

ADULT; AGED; ARTICLE; DEPRESSION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY MEDICAL CARE; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; REMISSION; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; COST-BENEFIT ANALYSIS; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 67649331947     PISSN: 09337954     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00127-008-0463-5     Document Type: Article

References (35)

1. Brazier J, Deverill M, Green C, Harper R, Booth A (1999) A review of the use of health status measures in economic evaluation. Health Technol Assess 3:1-164
2. Brazier J, Roberts J, Deverill M (2002) The estimation of a preference-based measure of health from the SF-36. J Health Econ 21:271-292
3. Brazier JE, Akehurst R, Brennan A, Dolan P, Claxton K, McCabe C, Sculpher M, Tsuchyia A (2005) Should patients have a greater role in valuing health states? Appl Health Econ Health Policy 4(4):201-208
4. Brazier JE, Ratcliffe J, Tsuchiya A, Salomon J (2007) Measuring and valuing health benefits for economic evaluation. Oxford University Press, Oxford
5. Brazier JE, Roberts J, Tsuchiya A, Busschbach J (2004) A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 13:873-884
6. CCOHTA (1997) Guidelines for the economic evaluation of pharmaceuticals. Canadian Coordinating Office for Health Technology Assessment, Ottawa
7. Donaldson C, Currie G, Mitton C (2002) Cost effectiveness analysis in health care: Contraindications. BMJ 325:891-894
8. First M, Spitzer R, Gibbon M, Williams J (1996) Structured clinical interview schedule for DSM-IV axis/disorders, Clinical Version, (SCID-CV). American Psychiatric Press, Washington DC
9. Gilbody S, Richards D, Barkham M (2007) Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM. Br J Gen Pract 57:650-652
10. Gilbody S, Richards D, Brearly S, Hewitt C (2007) Screening for depression in medical settings with the patient health questionnaire (PHQ): A diagnostic meta-analysis. J Gener Int Med (in press)
11. Gold MR (1996) Cost-effectiveness in health and medicine. Oxford University Press, New York
12. Gunther OH, Roick C, Angermeyer MC, Konig H-H (2008) The responsiveness of EQ-5D utility scores in patients with depression: A comparison with instruments measuring quality of life, psychopathology and social functioning. J Affect Disord (in press)
13. Kaltenthaler E, Brazier J, De Nigris E, Tumur I, Ferriter M, Beverley C, Parry G, Rooney G, Sutcliffe P (2006) Computerised cognitive behaviour therapy for depression and anxiety update: A systematic review and economic evaluation. Health Technol Assess 10:iIi, xi-xiv, 1-168
14. Kroenke K, Spitzer R (2002) The PHQ-9: A new depression and diagnostic severity measure. Psychiatric Ann 32:509-521
15. Lamers LM, Bouwmans C, van Straten A, Donker M, Hakkaart L (2006) Comparison of EQ-5D and SF-6D utilities in mental health patients. Health Econ 15:1229-1236
16. Layard R (2006) The case for psychological treatment centres. BMJ 332:1030-1032
17. Longworth L, Bryan S (2003) An emprical comparison of EQ-5D and SF-6D in liver transplant patients. Health Econ 12:1061-1067
18. NICE (2007) Antenatal and postnatal mental health: Clinical guideline (CG45). HMSO, London
19. NICE (2004) Depression: Core interventions in the management of depression in primary care and secondary care. HMSO, London
20. NICE (2004) Guide to the methods of technology appraisal. HMSO, London
21. Papakostas GI, Petersen T, Mahal Y, Mischoulon D, Nierenberg AA, Fava M (2004) Quality of life assessments in major depressive disorder: A review of the literature. General Hospital Psychiatry 26:13-17
22. Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, Chatwin J, Goddard J, Thornett A, Smith H, Campbell M, Thompson C (2005) A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine. Health Technol Assess 9:1-134
23. Rawlins MD (2004) NICE work - providing guidance to the British National Health Service. N Engl J Med 351:1383-1385
24. Rawlins MD, Culyer AJ (2004) National Institute for clinical excellence and its value judgments. BMJ 329:224-227
25. Revicki DA, Wood M (1998) Patient-assigned health state utilities for depression-related outcomes: Differences by depression severity and antidepressant medications. J Affect Disord 48:25-36
26. Richards D, Lovell K, Gilbody S, Gask L, Torgerson D, Barkham M, Bland M, Bower P, Lankshear A, Simpson A, Fletcher J, Escott D, Henessey S, Richardson R (2007) Collaborative care for depression in UK primary care: A randomized controlled trial. Psychol Med (in press)
27. Sapin C, Fantino B, Nowicki M-L, Kind P (2004) Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health Qual Life Outcomes 2:20
28. Donald Sherbourne C, Unutzer J, Schoenbaum M, Duan N, Lenert LA, Sturm R, Wells KB (2001) Can utility-weighted health-related quality-of-life estimates capture health effects of quality improvement for depression? Med Care 39:1246-1259
29. Sobocki P, Ekman M, Agren H, Krakau I, Runeson B, Martensson B, Jonsson B (2007) Health-related quality of life measured with EQ-5D in patients treated for depression in primary care. Value Health 10:153-160
30. SPSS (2005) SPSS Base 14.0 User's Guide. SPSS Inc, Chicago
31. The EuroQol Group (1990) EuroQol-a new facility for the measurement of health related quality of life. The EuroQol Group. Health Policy 16:199-208
32. Thomas CM, Morris S (2003) Cost of depression among adults in England in 2000. Br J Psychiatry 183:514-519
33. Ware JE, Gandek B, Kosinski M, Snow KK (1993) SF-36 health survey: manual and interpretation guide. The Health Institute New England Medical Center, Boston
34. Williams A (1995) The measurement and valuation of health: A chronicle. discussion paper 136. In: Centre for health economics. York Health Economics Consortium, The University of York
35. World Health Organisation (2001) The World Health Report 2001: Mental health: New uNderstanding: new hope. World Health Organisation, Geneva